Mitsubishi UFJ Trust & Banking’s Dianthus Therapeutics DNTH Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$166K	Buy	+1,707	New	+$149K	﹤0.01%	1377

Other funds holding DNTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's DNTH Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Dianthus Therapeutics (DNTH) in Q2 2026: 1,707 shares worth $166K. The stake represents ﹤0.01% of the portfolio and ranks #1377 among its holdings.

75 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 1,707 shares of Dianthus Therapeutics worth $166K as of Q2 2026.
Dianthus Therapeutics was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
Dianthus Therapeutics made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1377 holding.
75 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.